Top Markets
Coin of the day
Hybio Pharmaceutical Co., Ltd. Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.

300199
Clasificación en acciones #5135
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
Precio por acción
$3.36
Capitalización bursátil
$2.97B
Cambio (1 día)
2.34%
Cambio (1 año)
-7.88%
País
CN
Comercio Hybio Pharmaceutical Co., Ltd. (300199)

Categoría

Historial del precio de la acción de Hybio Pharmaceutical Co., Ltd. (300199)
Precio más alto de cierre: $3.56 el 2026-08-01

Precio más bajo de cierre: $0.58 el 2011-04-01
Historial del precio de la acción de Hybio Pharmaceutical Co., Ltd. desde 2011 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 15.17%
2025 42.29%
2024 -6.38%
2023 -30.94%
2022 109.62%
2021 23.92%
2020 37.43%
2019 -46.61%
2018 -38.55%
2017 -7.67%
2016 -34.21%
2015 61.85%
2014 66.85%
2013 185.59%
2012 -33.66%
2011 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$164.46 30.68%
DE
$37.90 27.13%
JP
$222.40 27.19%
CH
$21.11 15.61%
IN